Hi Andrew,
Not sure if you've had an opportunity to read this article i posted a link to the other day. Well worth a read.
This is what my attention is on the moment...
Ex-vivo for CRISPR Cas9 could have a lot commercial interest.
https://labiotech.eu/features/crispr-cas9-drug-discovery/
Tony
Ann: Successful Delivery of CRIPR/Cas9 into Cells ex vivo, page-30
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.30 |
Change
-0.025(1.89%) |
Mkt cap ! $755.3M | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.32 | $1.30 | $478.1K | 365.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $1.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.32 | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |